April 24, 2007 edition
PT Sanbe Farma has been pushing its way through the market as a manufacturer of sterile infusion fluid. The effort, however, has been unsuccessful due to their steep prices. Meanwhile, all production at PT Otsuka Indonesia—supplier of 80 percent of the country’s infusion fluid—has been stopped by the Food & Drug Supervisory Agency. Otsuka’s method in preparing infusion fluid is not deemed as sterile and may harm those who use them.
Hospitals in Jakarta and Sumatra are experiencing an infusion fluid crisis. “This is a trade war in a business where corruption reaches trillions of rupiah,” says Iwan Darmansjah. Tempo has uncovered traces of lobbies for infusion fluid in a number of national organizations.
Read More
More International articles in other editions
April 3, 2007 edition
THE acquisition of land for the Eastern Flood Canal costing some Rp2.4 trillion is turning into a feeding frenzy. The funds are being embezzled in all sorts of ways, from manipulating land certificates to upgrading property values. The prosecutors’ offices and the police have only just begun dealing with a few of the many cases. The following is a Tempo report on the manipulation of funds for the canal project that spans some 23 kilometers.
Read More
March 20, 2007 edition